Hepatitis C Virus Protein Modulates Apoptosis in Liver Cells

Strategic Insights -

Researchers at Tokyo Medical and Dental University have found that a key protein from the hepatitis C virus (HCV) modulates apoptosis, or programmed cell death, in liver cells. The study, published in the Journal of Infectious Diseases, reveals that the nonstructural protein 5A (NS5A) of HCV inhibits apoptosis induced by tumor necrosis factor-alpha (TNF-alpha) in liver cells, with significant implications for our understanding of the virus's lifecycle and the development of effective treatments.

Key Takeaways:

  • The hepatitis C virus nonstructural protein 5A (NS5A) inhibits apoptosis in liver cells induced by TNF-alpha.
  • The study found that the viability of Huh7-NS5A cells was reduced only to 80% after TNF-alpha treatment, compared to 40% in control cells.
  • The inhibition of caspase-8 activation is responsible for the antiapoptotic effect of the NS5A protein.
  • The coexpression of NS5A did not inhibit apoptosis induced by caspase-8 or Fas-associating death domain protein expression.
  • These findings suggest that the NS5A protein inhibits the apoptotic effect of TNF-alpha upstream of caspase-8 in the apoptosis cascade.
  • Researchers conducted the study using Huh7 cells that stably express NS5A, and induced apoptosis using TNF-alpha.

Statistics:

  • The viability of control Huh7 cells was reduced to 40% after TNF-alpha treatment.
  • The viability of Huh7-NS5A cells was reduced only to 80% after TNF-alpha treatment.
  • DNA fragmentation decreased to in Huh7-NS5A cells, compared with control cells.
  • Nuclear factor kappa B activation was the same in both cell types.

Sources:

Journal of Infectious Diseases

Miyasaka, Y., et al. "Hepatitis C virus nonstructural protein 5A inhibits tumor necrosis factor-alpha-mediated apoptosis in Huh7 cells." Journal of Infectious Diseases, vol. 188, no. 10, 2003, pp. 1537-1544.

University of Chicago Press, 1427 E 60TH St., Chicago, IL 60637-2954 USA.